a biotech uncovering the next generation of medicines and high-value molecules hiding in soil bacteria
Generare has raised €25M across 2 funding rounds from 11 investors, most recently a Series A round in Apr 2026. Based in Paris, France; active in Healthtech. Data as of 6 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-04-02 | Series A | €20M | Alven,Daphni,Existing investors,Galion.exe,TeamPact Ventures,VIVES Partners | View deal → |
| 2024-10-08 | Seed | €5.0M | Better Angle,Business Angels,Galion.exe,Saras Capital,Synbioven,Teampact.ventures+1 more | View deal → |
